Markets slip as pharma deals and oil fears grip traders

🌅 Today's Morning Call

S&P Futures 7,584.50 ▼ -21.50 (-0.28%)	Nasdaq Futures 30,403.50 ▼ -63.25 (-0.21%)	Dow Futures 52,422.00 ▼ -118.00 (-0.22%)
10Y Treasury 4.43% ▼ -0.04%	US Dollar 99.68 ▲ +0.15 (+0.15%)	Bitcoin $64,798 ▼ -$819 (-1.25%)

Good morning! Wednesday, June 17, 2026 is arriving with a cautious mood across futures markets, as all three major indexes tick lower heading into the open. Pharma is making noise with a blockbuster antibody deal, used-car names are in focus after CarMax crushed earnings, and oil supply worries are keeping commodity traders on their toes. Here is everything you need to know before the bell rings.

👀 What to Watch Today

The macro calendar is relatively light today, which means the market narrative will be driven more by earnings momentum and sector-specific news than by any single data point. Traders will be watching how CarMax (KMX) opens after that earnings beat, and whether strength in used-vehicle retail lifts the broader auto sector. Any commentary from the company on consumer spending and credit conditions could set the tone for discretionary names today.

On the regulatory front, the UK's Competition and Markets Authority has outlined new conduct requirements for Google Search (GOOG, GOOGL). While enforcement timelines are still being worked out, any update on how Alphabet plans to respond could become a headline mover for mega-cap tech.

With Juneteenth on Friday shortening the week, volume patterns may shift as institutional desks start wrapping up positioning a little earlier than usual. Keep an eye on mid-session liquidity, which can get choppy ahead of a market holiday.

Trump Planning to Use Public Law 63-43: Prepare Now [ad]

🌏 Overnight Recap

Overnight, global markets traded with a cautious bias. European indexes opened mixed as traders digested the IEA's latest oil supply outlook, which projects a meaningful rebound toward 8 million barrels per day by 2027 but acknowledges that a gradual normalization through the Strait of Hormuz will keep supply tight for months. Energy ETFs including GUSH and BNO are worth watching at the open.

In Asia, Toyota (TM) made headlines at its annual shareholder meeting, where investors formally backed Akio Toyoda as chairman and approved Kenta Kon as the incoming CEO. The leadership transition had been widely anticipated, and markets appeared to take it in stride. Japanese automaker stocks held relatively steady overnight.

Treasury yields are nudging lower across the curve this morning, with the 10-year sitting at 4.43 percent and the 30-year at 4.93 percent. That modest relief on rates is not quite enough to lift futures into positive territory, suggesting the soft open is more about sector-specific uncertainty than a pure macro selloff.

Executive Order 14330: Trump’s Biggest Yet [ad]

📊 Pre-Market Movers

CarMax (KMX) is the clear standout in pre-market trading after the used-vehicle retailer delivered a first-quarter earnings beat that came in comfortably ahead of Wall Street's expectations. Shares are moving higher ahead of the open, and the result is drawing fresh attention to the broader auto retail space. Rival Carvana (CVNA) is also in the spotlight after news broke that the company is piloting a new-car sales model at a Dallas location, converting it into a test-drive center rather than a traditional dealership. That is a meaningful strategic shift worth watching.

In biotech, AbCellera (ABCL) is the name to watch after Jazz Pharmaceuticals (JAZZ) announced a research collaboration and licensing deal worth up to 876 million dollars to develop T-cell-engaging antibodies for cancer treatment. Both stocks could see significant volume at the open.

Meanwhile, UniQure (QURE) received a green light from the FDA to pursue accelerated approval for its Huntington's gene therapy based on mid-stage trial data. For a small-cap biotech, that kind of regulatory milestone often translates directly into a sharp pre-market move. Moderna (MRNA) is also drawing attention after CEO Stephane Bancel signaled interest in acquiring BioNTech (BNTX) production facilities in Germany.

One firm just put $705 million into a stock nobody’s heard of [ad]

🔍 Today's Watchlist

1. KMX: CarMax earnings beat is the headline catalyst in auto retail. Watch the opening print closely and listen for any guidance on consumer credit trends.
2. JAZZ and ABCL: The up-to-876 million dollar antibody collaboration deal is a significant catalyst for both names. AbCellera in particular could see outsized movement.
3. QURE: UniQure just received FDA clearance to file for accelerated approval of its Huntington's gene therapy. This is a major regulatory milestone for a small-cap biotech.
4. Oil ETFs (GUSH, BNO, DBO): The IEA's commentary on Gulf supply disruption and a multi-month recovery timeline keeps energy names volatile. Monitor crude prices at the open.
5. GOOG and GOOGL: UK regulatory conduct requirements land at a sensitive time for Alphabet. Any signal about compliance costs or search monetization impact matters for the stock.

🎯 The Morning Playbook

Today's session is shaping up to be a stock-picker's day rather than a macro macro story. Futures are modestly lower but not in free fall, which means the real action will likely come from individual names reacting to earnings, deals, and regulatory news. KMX, ABCL, JAZZ, and QURE all have fresh catalysts that could drive significant moves independent of where the broader indexes land.

For investors watching the energy space, the IEA's updated supply forecast is a reminder that the Gulf disruption is not a short-term blip. Oil supply normalization is expected to take months, which keeps names like GUSH and the broader energy sector in a tense holding pattern. Position sizing matters here.

With the holiday weekend approaching and volume likely to thin out by Thursday afternoon, today is one of the better days this week to act on conviction. Do your homework on the movers with real catalysts, stay disciplined on the ones driven by noise, and remember that short weeks can amplify both the good days and the rough ones.

Distracted Americans set to miss out on quadrillions [ad]